We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
Curcumin wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
8 of 10 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
5 of 6 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Curcumin and Huperzine A have evidence — compare verdict strength side-by-side.
500-1000mg daily (enhanced form)
With fatty meal
Enhanced absorption form: Longvida, Meriva, or BCM-95
50-200mcg twice daily
Morning and early afternoon, Avoid evening (may cause vivid dreams)
Huperzine A capsules (standardized extract)
4-8 weeks
4-8 weeks
4-8 weeks
Immediate
2-4 weeks
30-60 minutes
2-4 weeks
During use
Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis
Nutrients (2025) · Meta analysis · n=4599
Bayesian rankings indicated Boswellia had the highest probability of being most effective for pain and stiffness, with krill oil and curcumin showing potential for function improvement.
Curcumin on Human Health: A Comprehensive Systematic Review and Meta-Analysis of 103 Randomized Controlled Trials
Phytotherapy research : PTR (2024) · Meta analysis · n=7216
We meta-analyzed the effect sizes across eligible studies using the random-effects model.
Comparative efficacy and tolerability of nutraceuticals for depressive disorder: A systematic review and network meta-analysis
Psychological medicine (2025) · Meta analysis · n=17437
Adjunctive nutraceuticals consistently showed better efficacy than antidepressants (ADT) alone in outcomes including SMD, remission, and response.
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Traditional Chinese herbal medicine for vascular dementia
The Cochrane database of systematic reviews (2018) · Systematic review · n=3581
Two TCHMs (NaoMaiTai and TongXinLuo) had a 5% or more increased risk of AEs compared to the 'no Treatment' control, but the quality of this evidence was poor.
Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews
BMJ open (2016) · Systematic review · n=289
The quality of the reviews varied; however most (65%) scored 8/11 or more on the AMSTAR tool, indicating high quality.
Based on meta-analyses of arthritis and osteoarthritis studies. Effectiveness varies significantly by curcumin form - enhanced bioavailability formulations may show greater effects at lower doses. Limited high-quality RCTs available.
Based on meta-analysis showing MMSE improvement (WMD: 2.27) in dementia populations. Evidence primarily from dementia patients, limited data in healthy individuals. Quality concerns noted in systematic reviews regarding study methodology.
AI-estimated from published studies. Interpret as directional guidance.
Curcumin has a higher evidence score (9/10 vs 7.5/10) and wins in 3 of 3 categories.
For neuroprotection, Curcumin has a higher relevance score (80 vs 75).
No known interactions between Curcumin and Huperzine A have been documented in our database. However, always consult a healthcare provider before combining supplements.